Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.22 (
cdc2
)
8,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rap1, a growth regulatory protein that is strongly expressed in human squamous cell carcinoma (SCC), is inactivated by
rap1GAP
. Recent evidence in normal rat cells suggests that
rap1GAP
regulates proliferation. The objective of the current study was to investigate whether
rap1GAP
functions as a tumor suppressor in SCC. Using a pull-down assay, active GTP-bound rap1 was up-regulated in SCC compared to normal or immortalized keratinocytes. Because both rap1A and rap1B isoforms of rap1 are expressed in SCC, the
rap1GAP
inactivation of both rap1 isoforms was verified using cells transfected with EGFP-rap1A or EGFP-rap1B or co-transfected with FLAG-tagged
rap1GAP
. The results demonstrate that expression of
rap1GAP
in oropharyngeal SCC down-regulated active rap1, ERK activation, and proliferation. Incubation of stably transfected SCC cells with nocodazole, an inhibitor of mitosis, caused a slower accumulation of
rap1GAP
-transfected cells in the G2 phase, in comparison to the vector control, indicating that
rap1GAP
-transfected cells have slower progression through the cell cycle. This was supported by down-regulation of cyclin D1,
cdk4
, and
cdk6
in
rap1GAP
-transfected SCC cells. Furthermore, SCC cells transfected with
rap1GAP
produced significantly smaller tumors in nude mice as compared to controls (P < 0.01). These novel findings suggest that
rap1GAP
acts as a tumor suppressor protein in SCC.
...
PMID:Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma. 1643 72